about
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whe...
Read More
3.92
-0.05
(-1.26%)
50,208
XNAS Volume
XNAS 20 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
No Score Avaliable
NervGen Pharma Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..